Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 09:53 am Purchase | 2024-09-30 | 13G | Theravance Biopharma, Inc. TBPH | Madison Avenue Partners LP | 9,511,150 19.400% | 999,800 (+11.75%) | Filing History |
| 2024-11-12 5:53 pm Unchanged | 2024-09-30 | 13G | Theravance Biopharma, Inc. TBPH | The Vanguard Group | 2,051,689 4.190% | 0 (Unchanged) | Filing History |
| 2024-11-04 3:33 pm Unchanged | 2024-09-30 | 13G | Theravance Biopharma, Inc. TBPH | The Vanguard Group | 2,051,689 4.190% | 0 (Unchanged) | Filing History |
| 2024-11-04 2:10 pm Sale | 2024-09-30 | 13G | Theravance Biopharma, Inc. TBPH | The Vanguard Group | 2,051,689 4.190% | -1,437,573 (-41.20%) | Filing History |
| 2024-10-24 4:44 pm Sale | 2024-09-30 | 13G | Theravance Biopharma, Inc. TBPH | BlackRock Inc. BLK | 3,728,382 7.600% | -856,214 (-18.68%) | Filing |
| 2024-09-09 5:42 pm Sale | 2024-08-31 | 13G | Theravance Biopharma, Inc. TBPH | BAUPOST GROUP LLC | 0 0.000% | -2,977,304 (Position Closed) | Filing History |
| 2024-08-16 4:05 pm Purchase | 2024-08-07 | 13G | Theravance Biopharma, Inc. TBPH | Newtyn Management LLC | 4,100,000 8.400% | 4,100,000 (New Position) | Filing History |
| 2024-08-09 4:14 pm Sale | 2024-07-31 | 13G | Theravance Biopharma, Inc. TBPH | BAUPOST GROUP LLC | 2,977,304 6.120% | -4,441,922 (-59.87%) | Filing History |
| 2024-06-11 4:17 pm Sale | 2024-05-10 | 13G | Theravance Biopharma, Inc. TBPH | ODRE 2005 SLU | 0 0.000% | -4,108,318 (Position Closed) | Filing History |
| 2024-05-03 5:49 pm Purchase | 2024-05-01 | 13G | Theravance Biopharma, Inc. TBPH | Madison Avenue Partners LP | 8,511,350 17.500% | 1,499,124 (+21.38%) | Filing History |
| 2024-03-05 09:01 am Unchanged | 2024-03-01 | 13D | Theravance Biopharma, Inc. TBPH | Weiss Asset Management LP | 7,457,060 15.500% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:00 pm Purchase | 2023-12-31 | 13G | Theravance Biopharma, Inc. TBPH | Irenic Capital Management LP | 2,760,948 5.500% | 2,760,948 (New Position) | Filing History |
| 2024-02-13 5:15 pm Sale | 2023-12-29 | 13G | Theravance Biopharma, Inc. TBPH | The Vanguard Group | 3,489,262 7.010% | -2,069,577 (-37.23%) | Filing History |
| 2024-02-08 4:54 pm Sale | 2023-12-31 | 13G | Theravance Biopharma, Inc. TBPH | BlackRock Inc. BLK | 4,584,596 9.200% | -745,234 (-13.98%) | Filing |
| 2023-08-14 5:05 pm Unchanged | 2023-08-09 | 13D | Theravance Biopharma, Inc. TBPH | Weiss Asset Management LP | 7,457,060 14.120% | 0 (Unchanged) | Filing History |
| 2023-07-10 4:33 pm Sale | 2023-06-30 | 13G | Theravance Biopharma, Inc. TBPH | BAUPOST GROUP LLC | 7,419,226 12.840% | -4,000,000 (-35.03%) | Filing History |
| 2023-04-12 1:51 pm Unchanged | 2023-04-11 | 13D | Theravance Biopharma, Inc. TBPH | Weiss Asset Management LP | 7,457,060 11.790% | 0 (Unchanged) | Filing History |
| 2023-02-14 5:07 pm Sale | 2022-12-31 | 13G | Theravance Biopharma, Inc. TBPH | ORBIMED ADVISORS LLC | 0 0.000% | -5,456,780 (Position Closed) | Filing History |
| 2023-02-14 09:58 am Purchase | 2022-12-31 | 13G | Theravance Biopharma, Inc. TBPH | Madison Avenue Partners LP | 7,012,226 10.400% | 364,201 (+5.48%) | Filing History |
| 2023-02-13 4:41 pm Sale | 2023-02-13 | 13G | Theravance Biopharma, Inc. TBPH | BAUPOST GROUP LLC | 11,419,226 16.950% | -3,111,770 (-21.41%) | Filing History |